CSI Market
Sign In | Register

Biomarin Pharmaceutical Inc (BMRN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BMRN Annual Balance Sheets →
Looking at balance sheet data from Biomarin Pharmaceutical Inc through Sep 30 2025 provides insight into Sep 30 2026's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BMRN/balance-sheets
https://api.csimarket.com/api/v1/companies/BMRN/fundamentals
https://api.csimarket.com/api/v1/companies/BMRN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent736.01
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments736.00
Accounts receivable1,076.36
Inventories1,796.07
Other Current Assets312.21
Total Current Assets3,920.64
Equipment/Property/Plant Net2,111.01
Goodwill net666.37
Intangible Assets4,777.25
Long-term investments0.00
Other Assets, Noncurrent93.97
Total Assets11,569.23
Liabilities
Accounts Payable and Accrued Liabilities, Current LI946.11
Accrued Liabilities, Current246.44
Financial Instruments34.43
Convertible Debt, Current LO658.72
Taxes Payable28.25
Total Current Liabilities1,604.82
Long-term debt4,173.69
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt4,173.69
Other liabilities, Noncurrent0.00
Total Liabilities5,313.20
Stockholders' Equity
Common Stock Value0.19
Additional Paid In Capital Common Stock6,089.04
Retained Earnings / Accumulated Deficit181.66
Accumulated Other Comprehensive Income-4.01
Defined Benefit Plan and Other10.85
Other Equity-4.01
Common Stockholder's Equity6,256.03
Total Stockholder's Equity6,256.03
Liabilities & Stockholder's Equity11,569.23
4 historic quarters locked

Sign in to unlock the full Biomarin Pharmaceutical Inc balance sheet history.

Sign In Create Free Account

About Biomarin Pharmaceutical Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001048477-26-000023

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI